Legal Opinion
Novozymes A/S v. DuPont Nutrition Biosciences APS
Court of Appeals for the Federal Circuit
Decided July 22, 2013No. 2012-1433PublishedCited by 32 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge SCHALL.
Dissenting opinion filed by Chief Judge RADER.
SCHALL, Circuit Judge.
Plaintiffs-Appellants Novozymes A/S and Novozymes North America, Inc. (col*1338lectively, “Novozymes”) and DefendantsAppellees DuPont Nutrition Biosciences APS, Genencor International Wisconsin, Inc., Danisco U.S. Inc., and Danisco USA Inc. (collectively, “DuPont”) are competitors in the market for enzyme preparations used in a variety of commercial applications, including ethanol production. On May 11, 2010, Novozymes brought suit against DuPont in the Western District of…
2Cases cited17 opinions
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
- The Regents of the University of California v. Eli Lilly and CompanyCourt of Appeals for the Federal Circuit · 1997
- George Harper and Robert Padilla v. Lieutenant AlbertCourt of Appeals for the Seventh Circuit · 2005
- Uniloc USA, Inc. v. Microsoft Corp.Court of Appeals for the Federal Circuit · 2011
12 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- Danisco U.S. Inc. v. Novozymes A/SCourt of Appeals for the Federal Circuit · 2014
- Centrak, Inc. v. Sonitor Technologies, Inc.Court of Appeals for the Federal Circuit · 2019
- Erfindergemeinschaft UroPep GbR v. LillyDistrict Court, E.D. Texas · 2017
- Inphi Corporation v. Netlist, Inc.Court of Appeals for the Federal Circuit · 2015
- Biogen International Gmbh v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2021
27 more not listed; retrieve them via the Exa API.